R. M. HELDEN is an author at University of Hertfordshire specializing in monoamine neurotransmitters, drug discovery, and medicine.
Top concepts
MedicineBiochemistryPharmacologyDrug DiscoveryMolecular PharmacologyMonoamine Neurotransmitters
Publications per year
1996–1996
1
1
Novel 6-substituted 2-aminotetralins with potent and selective affinity for the dopamine D3 receptor
Peter Murray, R. M. HELDEN, Martin R. Johnson et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 29 citations
Molecular Pharmacology, Novel 6-Substituted 2-Aminotetralins, Selective Affinity +10
Rows per page
1–1 of 1